Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Submucosal cholinergic enteric neurons are a specialized population of neurons located within the submucosal (Meissner's) plexus of the gastrointestinal tract (Furness, J. B., 2006, The Enteric Nervous System). These neurons primarily utilize acetylcholine as their neurotransmitter to regulate critical physiological processes, including epithelial electrolyte and water secretion, local blood flow, and the release of gastrointestinal hormones (Brookes, S. J., et al., 2013, Nature Reviews Gastroenterology & Hepatology). They function as secretomotor neurons, receiving inputs from sensory neurons and interneurons to coordinate the mucosal response to luminal stimuli (Qu, Z. D., et al., 2008, Journal of Comparative Neurology). Dysregulation of these neurons is implicated in various functional and inflammatory gastrointestinal disorders, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), where altered secretory patterns contribute to symptoms like diarrhea or constipation (Sharkey, K. A., & Mawe, G. M., 2023, Gastroenterology). Pharmacological targeting of the cholinergic signaling pathways associated with these neurons involves the use of muscarinic agonists or acetylcholinesterase inhibitors to enhance secretion, or antagonists to reduce hypersecretion (Gautam, D., et al., 2004, Journal of Clinical Investigation).
Drugs modulate these neurons by acting as agonists or antagonists at muscarinic or nicotinic receptors, or by inhibiting acetylcholinesterase to increase synaptic acetylcholine levels, thereby stimulating or inhibiting intestinal secretion and motility.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Submucosal cholinergic enteric neuron.